Cytokinetics Inc (CYTK)
67.55
+0.55
(+0.82%)
USD |
NASDAQ |
Apr 19, 16:00
67.47
-0.08
(-0.12%)
After-Hours: 20:00
Cytokinetics 1 Year Total Returns (Daily): 82.07% for April 18, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 18, 2024 | 82.07% |
April 17, 2024 | 86.57% |
April 16, 2024 | 98.39% |
April 15, 2024 | 95.51% |
April 12, 2024 | 110.2% |
April 11, 2024 | 107.3% |
April 10, 2024 | 112.5% |
April 09, 2024 | 106.1% |
April 08, 2024 | 103.7% |
April 05, 2024 | 101.1% |
April 04, 2024 | 90.42% |
April 03, 2024 | 88.07% |
April 02, 2024 | 101.7% |
April 01, 2024 | 107.5% |
March 28, 2024 | 100.4% |
March 27, 2024 | 106.8% |
March 26, 2024 | 113.3% |
March 25, 2024 | 106.0% |
March 22, 2024 | 96.16% |
March 21, 2024 | 82.50% |
March 20, 2024 | 91.36% |
March 19, 2024 | 91.31% |
March 18, 2024 | 80.44% |
March 15, 2024 | 74.91% |
March 14, 2024 | 68.83% |
Date | Value |
---|---|
March 13, 2024 | 73.41% |
March 12, 2024 | 81.32% |
March 11, 2024 | 80.87% |
March 08, 2024 | 67.56% |
March 07, 2024 | 64.15% |
March 06, 2024 | 70.92% |
March 05, 2024 | 58.36% |
March 04, 2024 | 61.33% |
March 01, 2024 | 71.61% |
February 29, 2024 | 66.61% |
February 28, 2024 | 68.57% |
February 27, 2024 | 88.44% |
February 26, 2024 | 84.54% |
February 23, 2024 | 81.06% |
February 22, 2024 | 81.10% |
February 21, 2024 | 81.97% |
February 20, 2024 | 68.21% |
February 16, 2024 | 74.24% |
February 15, 2024 | 83.25% |
February 14, 2024 | 76.47% |
February 13, 2024 | 75.59% |
February 12, 2024 | 81.96% |
February 09, 2024 | 73.68% |
February 08, 2024 | 79.86% |
February 07, 2024 | 71.45% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-47.41%
Minimum
Oct 03 2023
178.1%
Maximum
Mar 18 2021
49.48%
Average
52.28%
Median
1 Year Total Returns (Daily) Benchmarks
Amgen Inc | 10.36% |
Johnson & Johnson | -6.71% |
Eli Lilly and Co | 103.3% |
Viking Therapeutics Inc | 217.6% |
Madrigal Pharmaceuticals Inc | -23.06% |